Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Regeneron Appoints Bayer's David Weinreich As SVP

This article was originally published in Scrip

Executive Summary

Regeneron Pharmaceutical, Inc. has appointed David Weinreich senior vice president late stage clinical development and medical affairs. With over 15 years' experience, Weinreich was previously senior vice president and head of global development for speciality medicine at Bayer Pharmaceuticals. Prior to this, he held various senior roles at Amgen in the oncology and development organization.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC064652

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel